Nursing care of severe hand foot syndrome caused by the oral anti-tumour drug Xeloda: a case study.
This case study summarises the nursing experience of a patient with grade III hand foot syndrome (HFS) caused by the oral anti-tumour drug Xeloda. The key points of nursing were a multi-disciplinary team consultation to make a clear diagnosis of grade III HFS, effectively control infection, apply a...
| Publicado en: | World Council of Enterostomal Therapists Journal Vol. 42; no. 1; pp. 29 - 34 |
|---|---|
| Autores principales: | , , |
| Formato: | case study pictorial Journal Article |
| Publicado: |
Cambridge Publishing
Mar2022
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| Sumario: | This case study summarises the nursing experience of a patient with grade III hand foot syndrome (HFS) caused by the oral anti-tumour drug Xeloda. The key points of nursing were a multi-disciplinary team consultation to make a clear diagnosis of grade III HFS, effectively control infection, apply a biocellulose dressing, and promote granulation growth and epidermal cell regeneration on the premise that the anti-tumour drug Xeloda cannot be reduced or stopped. After 98 days of comprehensive nursing intervention the wound healed completely; 6 months later, the ulcer did not reoccur. |
|---|